Analysis finds significant variations in national COVID-19 treatment recommendations

National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; WHO) treatment recommendations, finds a comparative analysis published in the open access journal BMJ Global Health.

Alnylam’s big Phase 3 win; LGBTQ+ leaders charting paths; Chevron overturned; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 30, 2024

Study Reinforces CVD, Other Non-Cancer Causes of Death in Men With Prostate Cancer

Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated

February 27, 2025

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring – Psychedelic Alpha

In this Issue The Psychedelic Blame Game: NYT Report Fuels Controversy Over MDMA Rejection Mixed Messages on Psymposia’s Role Lykos and MAPS Seize the Opportunity

February 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.